NATIONAL HEALTH INVESTORS INC (NHI)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue TTM

0 150M 300M 450M Q3 '16: 242.1M Q4 '16: 248.5M Q1 '17: 255.8M Q2 '17: 264.4M Q3 '17: 272.5M Q4 '17: 278.6M Q1 '18: 285M Q2 '18: 288.1M Q3 '18: 291.7M Q4 '18: 294.6M Q1 '19: 298M Q2 '19: 303.1M Q3 '19: 309.9M Q4 '19: 318.1M Q1 '20: 325.1M Q2 '20: 331.1M Q3 '20: 333.7M Q4 '20: 332.8M Q1 '21: 330.6M Q2 '21: 320.8M Q3 '21: 310.3M Q4 '21: 298.7M Q1 '22: 289.2M Q2 '22: 274.7M Q3 '22: 277.2M Q4 '22: 278.2M Q1 '23: 289.3M Q2 '23: 307.2M Q3 '23: 311M Q4 '23: 319.8M Q1 '24: 319M Q2 '24: 326.1M Q3 '24: 328.9M Q4 '24: 335.2M Q1 '25: 343M Q2 '25: 348.7M Q3 '25: 355.6M Q4 '25: 375.6M Q1 '26: 401.5M Q2 '26: 432.1M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Gross Profit TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Income TTM

0 40M 80M 120M Q4 '09: 48.7M Q1 '10: 50.3M Q2 '10: 54.2M Q3 '10: 54.9M Q4 '10: 61.9M Q1 '11: 64.1M Q2 '11: 72.8M Q3 '11: 75.4M Q4 '11: 67.4M Q1 '12: 69.1M Q2 '12: 61.2M Q3 '12: 56.7M Q4 '12: 72.8M Q1 '13: 69.8M Q2 '13: 72.5M Q3 '13: 81.5M Q4 '13: 79.5M Q1 '14: 89.1M Q2 '14: 96.2M Q3 '14: 99.4M Q4 '14: 103M Q2 '10 Q1 '11 Q4 '11 Q3 '12 Q2 '13 Q1 '14 Q4 '14

Net Income TTM

0 70M 140M 210M Q3 '16: 164.7M Q4 '16: 151.5M Q1 '17: 163M Q2 '17: 156.7M Q3 '17: 162.8M Q4 '17: 159.4M Q1 '18: 153.6M Q2 '18: 153.2M Q3 '18: 155M Q4 '18: 154.3M Q1 '19: 151.6M Q2 '19: 153.7M Q3 '19: 155.5M Q4 '19: 160.5M Q1 '20: 185.8M Q2 '20: 190.2M Q3 '20: 190M Q4 '20: 185.1M Q1 '21: 159.4M Q2 '21: 154.2M Q3 '21: 142.5M Q4 '21: 111.8M Q1 '22: 84.9M Q2 '22: 67.4M Q3 '22: 71M Q4 '22: 66.4M Q1 '23: 92.5M Q2 '23: 110.6M Q3 '23: 105.5M Q4 '23: 135.7M Q1 '24: 132.1M Q2 '24: 127.6M Q3 '24: 126.8M Q4 '24: 138M Q1 '25: 141.2M Q2 '25: 142.9M Q3 '25: 147.3M Q4 '25: 142.2M Q1 '26: 148.1M Q2 '26: 166.8M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Cost of Revenue TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Cash Flow TTM

0 90M 180M 270M Q3 '16: 172.9M Q4 '16: 176.6M Q1 '17: 184M Q2 '17: 188.4M Q3 '17: 193.3M Q4 '17: 198.1M Q1 '18: 198.3M Q2 '18: 205.4M Q3 '18: 208.4M Q4 '18: 207.9M Q1 '19: 232.8M Q2 '19: 232.6M Q3 '19: 236.4M Q4 '19: 241M Q1 '20: 224.2M Q2 '20: 230.8M Q3 '20: 232.7M Q4 '20: 232.1M Q1 '21: 232M Q2 '21: 223.9M Q3 '21: 213.1M Q4 '21: 210.9M Q1 '22: 192.6M Q2 '22: 197.8M Q3 '22: 192.3M Q4 '22: 185.3M Q1 '23: 177.7M Q2 '23: 171.4M Q3 '23: 177.6M Q4 '23: 184.4M Q1 '24: 194.2M Q2 '24: 204.5M Q3 '24: 203.4M Q4 '24: 207.8M Q1 '25: 213.4M Q2 '25: 212.5M Q3 '25: 226.4M Q4 '25: 236.6M Q1 '26: 243.5M Q2 '26: 248.7M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Free Cash Flow TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Shares Outstanding Quarterly

0 20M 40M 60M Q2 '15: 37.6M Q3 '15: 37.6M Q4 '15: 37.7M Q1 '16: 38.4M Q2 '16: 38.6M Q3 '16: 39.7M Q4 '16: 40M Q1 '17: 40.1M Q2 '17: 41.2M Q3 '17: 41.4M Q4 '17: 41.8M Q1 '18: 41.6M Q2 '18: 41.8M Q3 '18: 42.4M Q4 '18: 42.6M Q1 '19: 43.1M Q2 '19: 43.5M Q3 '19: 43.9M Q4 '19: 44.3M Q1 '20: 44.6M Q2 '20: 44.7M Q3 '20: 44.7M Q4 '20: 44.9M Q1 '21: 45.4M Q2 '21: 45.9M Q3 '21: 45.9M Q1 '22: 45.9M Q2 '22: 45.7M Q3 '22: 44.4M Q1 '23: 43.4M Q2 '23: 43.4M Q3 '23: 43.4M Q1 '24: 43.4M Q2 '24: 43.6M Q3 '24: 44M Q1 '25: 45.9M Q2 '25: 46.8M Q3 '25: 47.6M Q1 '26: 48.5M Q2 '26: 48.5M Q2 '16 Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q1 '23 Q3 '24 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

0.00 1.50 3.00 4.50 Q3 '16: 4.28 Q4 '16: 3.87 Q1 '17: 4.12 Q2 '17: 3.89 Q3 '17: 4.00 Q4 '17: 3.87 Q1 '18: 3.69 Q2 '18: 3.67 Q3 '18: 3.70 Q4 '18: 3.67 Q1 '19: 3.58 Q2 '19: 3.59 Q3 '19: 3.59 Q4 '19: 3.67 Q1 '20: 4.21 Q2 '20: 4.28 Q3 '20: 4.26 Q4 '20: 4.14 Q1 '21: 3.55 Q2 '21: 3.41 Q3 '21: 3.13 Q4 '21: 2.43 Q1 '22: 1.83 Q2 '22: 1.45 Q3 '22: 1.56 Q4 '22: 1.48 Q1 '23: 2.09 Q2 '23: 2.54 Q3 '23: 2.44 Q4 '23: 3.13 Q1 '24: 3.05 Q2 '24: 2.94 Q3 '24: 2.91 Q4 '24: 3.13 Q1 '25: 3.16 Q2 '25: 3.14 Q3 '25: 3.18 Q4 '25: 3.02 Q1 '26: 3.10 Q2 '26: 3.46 Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.